• OUR STATEMENT ON COVID-19
    • About Us
    • Pipeline
    • Therapeutic focus
    • Contact us
    • Investors

    Investors

    Press Releases:

    May 6, 2021 Anebulo IPO Pricing

    SEC Filings:

    May 17, 2021 Schedule 13D Aron English

    May 17, 2021 Form 4A Aron English

    May 6, 2021 Final Prospectus

    May 7, 2021 Form 4 Aron English

    May 6, 2021 Form 3 Rex Merchant

    May 6, 2021 Form 3 Daniel Schneeberger

    May 6, 2021 Form 3 Joseph Lawler

    May 6, 2021 Form 3 Aron English

    May 6, 2021 Form 3 Karah Parschauer

    May 6, 2021 Form 3 Areta Kupchyk

    May 6, 2021 Form 3 Kenneth Lin

    May 6, 2021 Form 3 Jason Aryeh

    April 26, 2021 Anebulo Pharmaceuticals, Inc Form S-1A

    April 26, 2021 Anebulo Roadshow Presentation

    Governance:

    Anebulo Bylaws

    Audit Committee Charter

    Compensation Committee Charter

    Nomination & Governance Committee Charter

    Code of Ethics – Executives

    Code of Ethics

    Whistleblower Policy

    • Twitter
    • Instagram

    Contact

    Anebulo Pharmaceuticals
    1017 Ranch Road 620 South
    Suite 107
    Lakeway, TX 78734
    Phone: 512-598-0931
    Email: info@anebulo.com

    About

    Our Mission
    Management Team
    Board of Directors

    Pipeline

    • ANEB-001

    ©2020 Anebulo Pharmaceuticals. All Rights Reserved.

    Privacy Policy | Terms of Use